Company profile: Bio Products Laboratory
1.1 - Company Overview
Company description
- Provider of plasma collection and plasma-derived medicines, headquartered in the UK and delivering life-saving treatments worldwide for immune deficiencies, bleeding disorders, infectious diseases, and critical care. Operates 29 US donor centers and supplies human albumin (approved for the Chinese market), plus immunology, critical care, and coagulation disorder products.
Products and services
- Plasma-Derived Medicines: Produces medicines for immune deficiencies, bleeding disorders, infectious diseases, and critical care through complex transformation of plasma collected from US donors, plasma-derived
- Plasma Collection: Collects high-quality plasma from donors across 29 US centers, underpinning global life-saving treatments produced via complex plasma transformation, industrial-scale
- Human Albumin: Supplies human albumin derived from plasma, recently approved for the Chinese market, produced via complex transformation of US donor plasma, China-approved
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Bio Products Laboratory
Scienion
HQ: Germany
Website
- Description: Provider of ultra-low volume liquid handling systems and microarray technologies enabling multiparallel bioanalytics, high throughput screening, and high throughput microarray production in genomics. Offerings include automated dispensers (sciFLEXARRAYER), pico- to microliter non-contact printing (sciDROP PICO), single-cell isolation (CellenONE), functionalized slides (sciCHIPs), buffers (sciBUFFERs), and consumables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scienion company profile →
GenCell Biosystems
HQ: Ireland
Website
- Description: Provider of biological testing tools and molecular biology instruments, commercializing technologies based on its Composite Liquid Cell (CLC) platform, which enables a new method of confining, transporting, combining, processing and analysing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GenCell Biosystems company profile →
Cellesce
HQ: United Kingdom
Website
- Description: Provider of patient-derived organoid (PDO) technology and 3D organoids for drug discovery assays, offering fee-for-service custom development and scaled manufacturing of PDO lines, plus comprehensive enablement services including sourcing, line development, technology access, and quality management systems. Biochemical engineering expertise in cell expansion; based in Cardiff, UK.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cellesce company profile →
Labcyte
HQ: United States
Website
- Description: Provider of Echo Acoustic Liquid Handling systems and laboratory instrumentation for life sciences applications, using focused acoustic energy to eject nanoliter-scale droplets from one plate to another with high accuracy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Labcyte company profile →
ChemoMetec
HQ: Denmark
Website
- Description: Provider of user-friendly instruments and software for precise cell counting and viability, including NucleoCounter NC-202 and NC-200 automated cell counters, XcytoMatic 40 for cell density analysis, Via2-Cassette disposable sampling cassettes, and NC-View/NucleoView image-analysis software, serving production/R&D, GMP, quality control, clinical diagnostics, cell therapy, and large pharmaceutical applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ChemoMetec company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Bio Products Laboratory
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Bio Products Laboratory
2.2 - Growth funds investing in similar companies to Bio Products Laboratory
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Bio Products Laboratory
4.2 - Public trading comparable groups for Bio Products Laboratory
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →